Saptagir Laboratories Private incorporated in 2016, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories specifically focusing on Anti-Fungal and Anti-Platelets. Our vision is to attain market leadership in development of innovator molecules for the domestic and export market. We are one of the leading manufacturers in Asia for Terbinafine Hydrochloride, Prasugrel, Ezetimibe, Solifenacine Succinate and Pregabalin. DMF and EU Written Confirmation is available for our premier product; Terbinafine Hydrochloride. CEP & Korean DMF are under filing. The Saptagir manufacturing facility is a WHO-GMP facility located on the outskirts of Hyderabad, India. The facility is cGMP compliant meeting applicable regulatory standards in terms of Infrastructure and Quality Management Systems. Additionally, Saptagir Laboratories provides contract development and manufacturing services of APIs and INTs to generic companies, and also supports innovator companies in exclusive contract research and development of NCEs. The company, initially incorporated as Astrica Laboratories Private Limited, was renamed to Saptagir Laboratories subsequent to its acquisition by Saptagir Camphor Limited in 2019.